Predicted critical environmental concentrations for 500 pharmaceuticals

Regulatory Toxicology and Pharmacology

Volumn 58, Issue 3, 2010, Pages 516-523

  Fick, Jerker ^a   Lindberg, Richard H ^a   Tysklind, Mats ^a   Larsson, D G Joakim ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Fish plasma model; Non target species; Pharmacological interactions; Prioritizing; Ranking

Indexed keywords

ABACAVIR; ACAMPROSATE; ACETAZOLAMIDE; ACETYLCYSTEINE; ALFUZOSIN; AMBROXOL; AMILORIDE; AMSACRINE; ANTIINFECTIVE AGENT; ARIPIPRAZOLE; ARTICAINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; DICLOFENAC; DILTIAZEM; GEMFIBROZIL; HALOPERIDOL; IBUPROFEN; KETOPROFEN; LEVONORGESTREL; MEMANTINE; NAPROXEN; ORPHENADRINE; OXAZEPAM; PROPRANOLOL; SERTRALINE; SURFACE WATER; TRAMADOL; UNINDEXED DRUG; VERAPAMIL; DRUG; DRUG RESIDUE;

AQUATIC ENVIRONMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRITICAL ENVIRONMENTAL CONCENTRATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG TARGETING; FISH; LIMIT OF DETECTION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; WATER POLLUTANT; ANIMAL; AQUATIC SPECIES; DRUG TOXICITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; EUROPE; HUMAN; RISK ASSESSMENT;

ANIMALS; AQUATIC ORGANISMS; DRUG RESIDUES; DRUG TOXICITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; EUROPE; HUMANS; PHARMACEUTICAL PREPARATIONS; RISK ASSESSMENT; WATER POLLUTANTS, CHEMICAL;

EID: 79951831415     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2010.08.025     Document Type: Article

References (30)

1. Ankley G.T., Brooks B.W., Huggett D.B., Sumpter J.P. Repeating history: pharmaceuticals in the environment. Environ Sci. Technol. 2007, 41:8211-8217.
2. Besse J.P., Garric J. Human pharmaceuticals in surface waters implementation of a prioritization methodology and application to the French situation. Toxicol. Lett. 2008, 176:104-123.
3. Brooks B.W., Huggett D.B., Boxall A.B.A. Pharmaceuticals and personal care products: research needs for the next decade. Environ. Toxicol. Chem. 2009, 28:2469-2472.
4. Brown J.N., Paxeus N., Förlin L., Larsson D.G.J. Variations in bioconcentration of human pharmaceuticals from sewage effluents into fish blood plasma. Environ. Toxicol. Pharm. 2007, 24:267-274.
5. Castiglioni S., Bagnati R., Calamari D., Fanelli R., Zuccato E. A multiresidue analytical method using solid-phase extraction and high-pressure liquid chromatography tandem mass spectrometry to measure pharmaceuticals of different therapeutic classes in urban wastewaters. J. Chromatogr. A 2005, 1092:206-215.
6. Chen F., Mackey A.J., Stoeckert C.J., Roos D.S. OrthoMCLDB: querying a comprehensive multi-species collection of ortholog groups. Nucleic Acids Res. 2006, 34:D363-D368.
7. Desbrow C., Routledge E.J., Brighty G.C., Sumpter J.P., Waldock M. Identification of estrogenic chemicals in STW effluent. 1. Chemical fractionation and in vitro biological screening. Environ. Sci. Technol. 1998, 32:1549-1558.
8. Erickson R.J., Mckim J.M., Lien G.J., Hoffman A.D., Batterman S.L. Uptake and elimination of ionizable organic chemicals at fish gills: II. Observed and predicted effects of pH, alkalinity, and chemical properties. Environ. Toxicol. Chem. 2006, 25:1522-1532.
9. Fick J., Söderstrom H., Lindberg R.H., Phan C., Tysklind M., Larsson D.G.J. Contamination of surface, ground, and drinking water from pharmaceutical production. Environ. Toxicol. Chem. 2009, 28:2522-2527.
10. Fick J., Lindberg R.H., Parkkonen J., Arvidsson B., Tysklind M., Larsson D.G.J. Therapeutic levels of levonorgestrel detected in blood plasma of fish: results from screening rainbow trout exposed to treated sewage effluents. Environ. Sci. Technol. 2010, 44:2661-2666.
11. Fitzsimmons P.N., Fernandez J.D., Hoffman A.D., Butterworth B.C., Nichols J.W. Branchial elimination of superhydrophobic organic compounds by rainbow trout (Oncorhynchus mykiss). Aquat. Toxicol. 2001, 55:23-34.
12. Fu W.J., Franco A., Trapp S. Methods for estimating the bioconcentration factor of ionizable organic chemicals. Environ. Toxicol. Chem. 2009, 28:1372-1379.
13. Garric J., Vollat B., Duis K., Pery A., Junker T., Ramil M., Fink G., Ternes T. Effects of the parasiticide ivermectin on the cladoceran Daphnia magna and the green alga Pseudokirchneriella subcapitata. Chemosphere 2007, 69:903-910.
14. Gunnarsson L., Jauhiainen A., Kristiansson E., Nerman O., Larsson D.G.J. Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ. Sci. Technol. 2008, 42:5807-5813.
15. Huggett D.B., Cook J.C., Ericson J.F., Williams R.T. A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum. Ecol. Risk Assess. 2003, 9:1789-1799.
16. Huggett D.B., Ericson J.F., Cook J.C., Williams R.T. Plasma concentrations of human pharmaceuticals as predictors of pharmacological responses in fish. Pharmaceuticals in the Environment 2004, 373-386. Springer, Heidelberg, Germany. K. Kummerer (Ed.).
17. Jobling S., Beresford N., Nolan M., Rodgers-Gray T., Brighty G.C., Sumpter J.P., Tyler C.R. Altered sexual maturation and gamete production in wild roach (Rutilus rutilus) living in rivers that receive treated sewage effluents. Biol. Reprod. 2002, 66:272-281.
18. Larsson D.G.J., Adolfsson-Erici M., Parkkonen J., Pettersson M., Berg A.H., Olsson P.E., Förlin L. Ethinyloestradiol - an undesired fish contraceptive?. Aquat. Toxicol. 1999, 45:91-97.
19. Lindberg R., Jarnheimer P.A., Olsen B., Johansson M., Tysklind M. Determination of antibiotic substances in hospital sewage water using solid phase extraction and liquid chromatography/mass spectrometry and group analogue internal standards. Chemosphere 2004, 57:1479-1488.
20. Loos R., Gawlik B.M., Locoro G., Rimaviciute E., Contini S., Bidoglio G. EU-wide survey of polar organic persistent pollutants in European river waters. Environ. Pollut. 2009, 157:561-568.
21. Miguel-Queralt S., Hammond G.L. Sex hormone-binding globulin in fish gills is a portal for sex steroids breached by xenobiotics. Endocrinology 2008, 149:4269-4275.
22. Mimeault C., Woodhouse A.J., Miao X.S., Metcalfe C.D., Moon T.W., Trudeau V.L. The human lipid regulator, gemfibrozil bioconcentrates and reduces testosterone in the goldfish, Carassius auratus. Aquat. Toxicol. 2005, 73:44-54.
23. Nikolaou A., Meric S., Fatta D. Occurrence patterns of pharmaceuticals in water and wastewater environments. Anal. Bioanal. Chem. 2007, 387:1225-1234.
24. Owen S.F., Giltrow E., Huggett D.B., Hutchinson T.H., Saye J., Winter M.J., Sumpter J.P. Comparative physiology, pharmacology and toxicology of beta-blockers: mammals versus fish. Aquat. Toxicol. 2007, 82:145-162.
25. Owen S.F., Huggett D.B., Hutchinson T.H., Hetheridge M.J., Kinter L.B., Ericson J.F., Sumpter J.P. Uptake of propranolol, a cardiovascular pharmaceutical, from water into fish plasma and its effects on growth and organ biometry. Aquat. Toxicol. 2009, 93:217-224.
26. Parrot J.L., Blunt B.R. Life-cycle exposure of fathead minnows (Pimephales promelas) to an ethinylestradiol concentration below 1ng/L reduces egg fertilization success and demasculinizes males. Environ. Toxicol. Chem. 2005, 20:1216-1227.
27. Schulz M., Schmoldt A. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 2003, 58:447-474.
28. Tarazona J.V., Escher B.I., Giltrow E., Sumpter J., Knacker T. Targeting the environmental risk assessment of pharmaceuticals: facts and fantasies. Integr. Environ. Assess. Manag. 2010, 6:603-613.
29. Winter M.J., Owen S.F., Murray-Smith R., Panter G.H., Hetheridge M.J., Kinterz L.B. Using data from drug discovery and development to aid the aquatic environmental risk assessment of human pharmaceuticals: concepts, considerations, and challenges. Integr. Environ. Assess. Manag. 2010, 6:38-51.
30. Zeilinger J., Steger-Hartmann T., Maser E., Goller S., Vonk R., Länge R. Effects of synthetic gestagens on fish reproduction. Environ. Toxicol. Chem. 2009, 28:2663-2670.